Source – stuartbramhall.wordpress.com
- “…Results of new research done by the Marqués de Valdecilla University Hospital in Spain shows that a large number of COVID-19 patients – 82% of them, were found to have low levels of vitamin D, according to this new peer reviewed study published in the Journal of Clinical Endocrinology and Metabolism”
Spain: Study Shows 80% COVID Patients Deficient in Vitamin D
21st Century Wire | October 28, 2020
A new study has all but confirmed the link between COVID sufferers and Vitamin D deficiency. This latest study lends additional support to the argument that cheap therapeutics are already readily available to the public – a key point which further demolishes the US, UK government and Big Pharma narrative that “only a vaccine” can save the population from a rapidly waning ‘novel’ coronavirus which is still being used by politicians and the World Economic Forum to justify the continuation of highly damaging lockdown policies.
Results of new research done by the Marqués de Valdecilla University Hospital in Spain shows that a large number of COVID-19 patients – 82% of them, were found to have low levels of vitamin D, according to this new peer reviewed study published in the Journal of Clinical Endocrinology and Metabolism.
Evidence seems to suggest that out of the 216 tested, more men were affected by this condition than women.
Conversely, a control group showed that only 47% of people who didn’t have the virus were Vitamin D deficient.
Vitamin D is a hormone produced in the kidneys which aids in the regulation of calcium in the bloodstream.
According to researchers, one possible mechanism for the high risk to serious illness in low Vitamin D sufferers could be a clear increase in serum levels of inflammatory markers like D-dimer and ferritin used by the body to fight off an infection.
One specific note: researchers did not find a clear association with the levels of vitamin D and the severity of COVID, or a need to be sent to intensive care, or placed on a ventilator, or death.
According to researcher Dr Jose Hernandez, from the University of Cantabria, “One approach is to identify and treat vitamin D deficiency, especially in high-risk individuals such as the elderly, patients with comorbidities, and nursing home residents, who are the main target population for the COVID-19.”
Regarding the issue of treatment, Dr Hernandez added that, “Vitamin D treatment should be recommended in COVID-19 patients with low levels of vitamin D circulating in the blood since this approach might have beneficial effects in both the musculoskeletal and the immune system.”